Lymphoma (non Hodgkin's) - bendamustine (with rituximab): final scope
Lymphoma (non Hodgkin's) - bendamustine (with rituximab): final matrix
Lymphoma (non Hodgkin's) - bendamustine (with rituximab): NICE response to consultee and commentator comments on the draft scope
Lymphoma (non Hodgkin's) - bendamustine (with rituximab): equality impact assessment - scoping
Lymphoma (non Hodgkin's) - bendamustine (with rituximab): draft scope for consultation (post referral) October 2012
Lymphoma (non Hodgkin's) - bendamustine (with rituximab): draft matrix for consultation (post referral) October 2012
Lymphoma (non Hodgkin's) - bendamustine (with rituximab): draft scope for consultation (pre-referral) August 2010
Lymphoma (non Hodgkin's) - bendamustine (with rituximab): provisional matrix (pre-referral) August 2010